Jade Biosciences, Inc.

JBIO · NASDAQ
Analyze with AI
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Assets
Cash & Equivalents$33,751$23,491$22,397$54,197
Short-Term Investments$44,872$98,948$106,823$113,178
Receivables$0$0$0$0
Inventory$0$0$0$0
Other Curr. Assets$1,494$1,793$2,276$6,958
Total Curr. Assets$80,117$124,232$131,496$174,333
Property Plant & Equip (Net)$215$902$1,245$728
Goodwill$0$0$0$0
Intangibles$0$0$0$0
Long-Term Investments$0$0$0$0
Tax Assets$0$0$0$0
Other NC Assets$0$2,284$2,560$302
Total NC Assets$215$3,186$3,805$1,030
Other Assets$0$0$0$0
Total Assets$80,332$127,418$135,301$175,363
Liabilities
Payables$224$2,396$2,575$1,208
Short-Term Debt$417$420$385$192
Tax Payable$0$0$0$0
Deferred Revenue$0$0$0$0
Other Curr. Liab.$3,187$14,821$4,822$1,150
Total Curr. Liab.$3,828$17,637$7,782$2,550
LT Debt$0$255$705$382
Deferred Rev, NC$0$0$0$0
Deferred Tax Liab, NC$0$0$0$0
Other NC Liab.$70$70$71$13
Total NC Liab.$70$325$776$395
Other Liabilities$0$0$0$0
Cap. Leases$0$255$705$382
Total Liabilities$3,898$17,962$8,558$2,945
Equity
Pref Stock$0$0$0$0
Common Stock$3$3$2$2
Retained Earnings-$233,052-$163,424-$87,903-$36,392
AOCI$105$237-$466-$59
Other Equity$309,378$272,640$215,110$208,867
Total Equity$76,434$109,456$126,743$172,418
Supplemental Information
Minority Interest$0$0$0$0
Total Liab. & Tot. Equity$80,332$127,418$135,301$175,363
Net Debt-$33,334-$22,816-$21,307-$53,623